New Onset Isolated Granulomatous Dacryoadenitis During Etanercept Therapy

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)

Abstract

Anti-tumor necrosis factor alpha (TNF- α) biological agents can rarely cause sarcoid-like granulomatosis. A 20-year-old woman presented with a 1-month history of painful left upper eyelid swelling. She was on subcutaneous etanercept and methotrexate for 1 year for juvenile idiopathic arthritis. Imaging showed diffuse enlargement of the left and minimal enlargement of the right lacrimal gland. There was no finding in favor of sarcoidosis on systemic evaluation. Incisional biopsy of the left lacrimal gland revealed non-caseating granulomatous dacryoadenitis. The findings showed significant regression 1 month after cessation of Etanercept therapy. To the best of our knowledge, this report illustrates the first case of an isolated granulomatous dacryoadenitis during TNF-α antagonist therapy.

Original languageEnglish
Pages (from-to)1727-1729
Number of pages3
JournalOcular Immunology and Inflammation
Volume31
Issue number8
DOIs
Publication statusPublished - 2023

Keywords

  • Anti- tumor necrosis factor alpha
  • TNF- α
  • dacryoadenitis
  • etanercept
  • granulomatous dacryoadenitis
  • granulomatous dacryoadenitis
  • lacrimal gland

Fingerprint

Dive into the research topics of 'New Onset Isolated Granulomatous Dacryoadenitis During Etanercept Therapy'. Together they form a unique fingerprint.

Cite this